RARA CRAFT DATABASE for FDA Medical Devices
510(k)K210678

FDA DEVICE FACTS

implaFit® hip stems

Implantcast GmbH

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEAugust 17, 2022PRODUCT CODELZO

Indications for use

The indications for use for the proposed implaFit® hip stems are as follows: The implaFit® hip stems are indicated for use in cases of:

- Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis;

- Rheumatoid arthritis;

- Treatment of non -union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement that are unmanageable b y other techniques; and

- Revision of previously failed total hip arthroplasty. The implaFit® hip stems, when used in conjunction with the ic-Bipolar Heads , are intended for the following indications:

- Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis

- Rheumatoid arthritis

- Correction of functional deformity

- Treatment of non-union, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques. The implaFit® hip stems cementless are intended for uncemented, press -fit fixation. The implaFit® hip stems cemented are intended for cemented fixation.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026